These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21529437)

  • 41. Issues related to recombinant human growth hormone utilization and optimization in a health plan setting.
    Nickman NA; Dunn JD
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS11-5. PubMed ID: 22590768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acromegaly induced by growth hormone replacement therapy.
    Karges B; Pfäffle R; Boehm BO; Karges W
    Horm Res; 2004; 61(4):165-9. PubMed ID: 14707471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Psychosocially stunted growth masked as growth hormone deficiency].
    Doeker B; Simić-Schleicher ; Hauffa BP; Andler W
    Klin Padiatr; 1999; 211(5):394-8. PubMed ID: 10572896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study.
    Sävendahl L; Cooke R; Tidblad A; Beckers D; Butler G; Cianfarani S; Clayton P; Coste J; Hokken-Koelega ACS; Kiess W; Kuehni CE; Albertsson-Wikland K; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Konrad D; Landier F; Pfaeffle R; Sommer G; Thomas M; Tollerfield S; Zandwijken GRJ; Carel JC; Swerdlow AJ
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):683-692. PubMed ID: 32707116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing growth hormone therapy in growth hormone deficient children: what to do in the absence of hard evidence? Commentary on Rachmiel et al.: Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone (Horm Res 2007;68:236-243).
    Wit JM
    Horm Res; 2007; 68(5):244-7. PubMed ID: 17396035
    [No Abstract]   [Full Text] [Related]  

  • 47. Growth hormone treatment for short stature: a review of psychosocial assumptions and empirical evidence.
    Gardner M; Sandberg DE
    Pediatr Endocrinol Rev; 2011 Dec; 9(2):579-88; quiz 589. PubMed ID: 22397142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyradiculoneuropathy in boy with pituitary dwarfism treated with recombinant growth hormone.
    Sakurai T; Kodama S; Urata R; Komatsu M
    Endocr J; 1996 Oct; 43 Suppl():S127-8. PubMed ID: 9076360
    [No Abstract]   [Full Text] [Related]  

  • 49. Parent requests growth hormone for child with idiopathic short stature.
    Stein MT; Frasier SD; Stabler B
    J Dev Behav Pediatr; 2004 Oct; 25(5 Suppl):S79-83. PubMed ID: 15502539
    [No Abstract]   [Full Text] [Related]  

  • 50. [GH treatment in patients with idiopathic short stature].
    Longui CA
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):750-6. PubMed ID: 18797581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone, enhancement and the pharmaceuticalisation of short stature.
    Morrison M
    Soc Sci Med; 2015 Apr; 131():305-12. PubMed ID: 25455477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research on growth hormone (GH) and the insulin-like growth factors (IGFs).
    Le Roith D; Sonksen PH
    Growth Horm IGF Res; 1998 Feb; 8(1):1-2. PubMed ID: 10990438
    [No Abstract]   [Full Text] [Related]  

  • 53. Association between pituitary height and growth response to recombinant human growth hormone in prepubertal children with growth hormone deficiency.
    Zhang Z; Zhang X; Niu W; Yuan Y
    Endocrine; 2023 Feb; 79(2):287-291. PubMed ID: 36264534
    [No Abstract]   [Full Text] [Related]  

  • 54. Current status of growth hormone treatment for short children.
    Bacon GE
    Alpha Omegan; 1999; 92(2):24-7. PubMed ID: 10850227
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of initial high doses of growth hormone in the treatment of short children with deficient secretion of the hormone].
    Chaussain JL; Carel JC
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):107-10. PubMed ID: 11424605
    [No Abstract]   [Full Text] [Related]  

  • 56. Patient information page from The Hormone Foundation. Growth hormone deficiency in children.
    Castro LC; Rogol AD; Shulman DI
    J Clin Endocrinol Metab; 2011 Dec; 96(12):A35-6. PubMed ID: 22143839
    [No Abstract]   [Full Text] [Related]  

  • 57. [How safe is the recombinant human growth hormone?].
    Calzada-León R
    Rev Med Inst Mex Seguro Soc; 2017; 55(3):341-352. PubMed ID: 28440988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of children and adolescents with idiopathic short stature.
    Ranke MB
    Nat Rev Endocrinol; 2013 Jun; 9(6):325-34. PubMed ID: 23609338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood; adult stroke risk after growth hormone treatment in childhood: first do no harm.
    Stagnaro S
    Neurology; 2015 Apr; 84(15):1613-4. PubMed ID: 25870454
    [No Abstract]   [Full Text] [Related]  

  • 60. [Genotropin in the treatment of children with growth hormone deficiency].
    Kasatkina EP; Sokolovskaia VN; Murankova NM; Ibragimov GV
    Probl Endokrinol (Mosk); 1993; 39(5):94-6. PubMed ID: 8108362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.